Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in mice
- 30 November 1991
- journal article
- Published by Elsevier in Metabolism
- Vol. 40 (11) , 1213-1218
- https://doi.org/10.1016/0026-0495(91)90218-l
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Estrone treatment dissociates primary versus secondary consequences of "diabetes" (db) gene expression in miceDiabetes, 1986
- Improved glycemic control in C57Bl/KsJ (db/db) mice after treatment with the thermogenic beta-adrenoceptor agonist, BRL 26830Diabetes, 1985
- Further characterization of diabetes-like abnormalities in the T-KK mouseDiabetologia, 1974
- Studies in the diabetic mutant mouse: III. Physiological factors associated with alterations in beta cell proliferationDiabetologia, 1970
- Studies in the diabetic mutant mouse: II. Electron microscopy of pancreatic isletsDiabetologia, 1970
- Studies in the diabetic mutant mouse: I. Light microscopy and radioautography of pancreatic isletsDiabetologia, 1970
- Development of the obese-hyperglycaemic syndrome in miceDiabetologia, 1968
- Studies with the mutation, diabetes, in the mouseDiabetologia, 1967
- Diabetes, a New Mutation in the MouseScience, 1966
- THE INSULIN AND THE ZINC CONTENT OF NORMAL AND DIABETIC PANCREASJournal of Clinical Investigation, 1938